HEALTH Nightingale Health Oyj
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely, as well as multiomics analysis services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health Clinics to incorporate the company's metabolomic blood testing into Personalised Health Clinics' personalized, clinician-led healthcare services. Nightingale Health Oyj was incorporated in 2002 and is based in Helsinki, Finland.…
Industry Peers
Health Information ServicesKey Statistics
About Nightingale Health (HEL: HEALTH)
›
Nightingale Health (HEL: HEALTH) is listed on Nasdaq Helsinki, where its shares trade in EUR. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 101 employees.
The shares were at 1.730 EUR on 20 November 2026, down 29.0% over 52 weeks. Its 52-week range is 0.7860 EUR to 2.595 EUR: the price is 33.3% below the high and 120.1% above the low.
Its market capitalisation is 104.42M EUR.
Nightingale Health reports return on equity of -37.9%, an operating margin of -341.8% and revenue up 29.6% year over year.
It holds more cash than debt, a net cash position of 32.70M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 1.600 EUR is 7.5% below the current price.